Chemotherapy-induced thrombocytopenia in pediatric oncology: Scope of the problem and opportunities for intervention.
Melanie D DegliuominiKatherine ArmstrongAudrey MauguenEmily K SlotkinStephen S RobertsIra J DunkelMary ClouserMichael V OrtizGerald A SoffPublished in: Pediatric blood & cancer (2022)
The impact of CIT varied by the administered chemotherapy regimens and dose intensity of chemotherapy agents. This study demonstrated that CIT causes both marked platelet transfusion burden as well as treatment reduction and delay within certain solid tumor cohorts. This can lend to future studies aimed at reducing the burden of CIT and targeting the most at-risk populations.